Although there is a paucity of data on the relevance of ENO2 to the progression of breast and prostate cancers, ENO2 mRNA was found to be elevated in breast cancer lymph node metastases compared to primary breast tumors [125], which may suggest its role in breast cancer progression. Here, ENO2 is linked to breast carcinoma.